Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Focused ultrasound helps screen for heart disease in cats

Research out of the Cummings School of Veterinary Medicine at Tufts University suggests focused cardiac ultrasound, rather than a full echo workup, might be an effective way of screening for CVD in cats.

Thumbnail

ASNC releases multisocietal amyloidosis imaging guidelines

The American Society of Nuclear Cardiology, together with eight other nuclear medicine and cardiology societies, have published a consensus document outlining the best practices for imaging and diagnosing cardiac amyloidosis.

Thumbnail

Neural network IDs congestive heart failure with 100% accuracy

Researchers have successfully trained a convolutional neural network to detect congestive heart failure with 100% accuracy using data from just one heartbeat.

Thumbnail

Pocket-sized: Pointers for Using (& Not Using) Handheld Point-of-Care Echocardiography

Handheld POC echo has proven useful in- and outside of the emergency department, but physicians still have reservations.

Thumbnail

Transcarotid Access: The Future of Non-femoral TAVR?

The transcarotid approach to TAVR is becoming more common, according to research presented at TVT.19.

Thumbnail

ASNC publishes new amyloidosis imaging guidelines

“We anticipate that these expert multisocietal consensus recommendations on multimodality imaging in cardiac amyloidosis will standardize the diagnosis and improve the management of this highly morbid and underdiagnosed disease," wrote authors of the new guidelines published in the Journal of Nuclear Cardiology.

Thumbnail

Nuclear medicine, cardio groups reject proposed myocardial PET cuts

Multiple nuclear medicine and cardiology groups are working to oppose potential cuts to myocardial PET scans that were made possible by the CMS 2020 Medicare Physician Fee Schedule (MPFS) proposed rule, according to a joint statement.

Orchestra BioMed earns CE mark for BackBeat cardiac neuromodulation therapy

Orchestra BioMed, Inc., on Sept. 4 announced it received CE mark approval for its Moderato implantable pulse generation system, which delivers the company’s trademarked cardiac neuromodulation therapy to patients while simultaneously acting as a pacemaker.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.